Cargando…
Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition
Myeloperoxidase (MPO) is a highly abundant protein within the neutrophil that is associated with lipoprotein oxidation, and increased plasma MPO levels are correlated with poor prognosis after myocardial infarct. Thus, MPO inhibitors have been developed for the treatment of heart failure and acute c...
Autores principales: | Roth Flach, Rachel J., Su, Chunyan, Bollinger, Eliza, Cortes, Christian, Robertson, Andrew W., Opsahl, Alan C., Coskran, Timothy M., Maresca, Kevin P., Keliher, Edmund J., Yates, Phillip D., Kim, Albert M., Kalgutkar, Amit S., Buckbinder, Leonard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424399/ https://www.ncbi.nlm.nih.gov/pubmed/30889221 http://dx.doi.org/10.1371/journal.pone.0214150 |
Ejemplares similares
-
Myeloperoxidase PET Imaging Tracks Intracellular and Extracellular Treatment Changes in Experimental Myocardial Infarction
por: Zeller, Matthias W. G., et al.
Publicado: (2023) -
Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction
por: Ali, Muhammad, et al.
Publicado: (2016) -
Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles
por: Tong, Wei, et al.
Publicado: (2021) -
Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles
por: Tong, Wei, et al.
Publicado: (2022) -
Tracking Where the O’s Go
por: Kalgutkar, Amit S.
Publicado: (2015)